UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

Synthesis and Anti-Mycobacterium tuberculosis Activity of Imidazo[2,1-b][1,3]oxazine Derivatives against Multidrug-Resistant Strains

Fernandes, GFS; Manieri, KF; Bonjorno, AF; Campos, DL; Ribeiro, CM; Demarqui, FM; Ruiz, DAG; ... Dos Santos, JL; + view all (2023) Synthesis and Anti-Mycobacterium tuberculosis Activity of Imidazo[2,1-b][1,3]oxazine Derivatives against Multidrug-Resistant Strains. ChemMedChem , Article e202300015. 10.1002/cmdc.202300015. (In press). Green open access

[thumbnail of Synthesis and AntiMycobacterium tuberculosis.pdf]
Preview
Text
Synthesis and AntiMycobacterium tuberculosis.pdf - Published Version

Download (3MB) | Preview

Abstract

The emergence of multidrug-resistant strains of M. tuberculosis has raised concerns due to the greater difficulties in patient treatment and higher mortality rates. Herein, we revisited the 2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine scaffold and identified potent new carbamate derivatives having MIC90 values of 0.18–1.63 μM against Mtb H37Rv. Compounds 47–49, 51–53, and 55 exhibited remarkable activity against a panel of clinical isolates, displaying MIC90 values below 0.5 μM. In Mtb-infected macrophages, several compounds demonstrated a 1-log greater reduction in mycobacterial burden than rifampicin and pretomanid. The compounds tested did not exhibit significant cytotoxicity against three cell lines or any toxicity to Galleria mellonella. Furthermore, the imidazo[2,1-b][1,3]oxazine derivatives did not show substantial activity against other bacteria or fungi. Finally, molecular docking studies revealed that the new compounds could interact with the deazaflavin-dependent nitroreductase (Ddn) in a similar manner to pretomanid. Collectively, our findings highlight the chemical universe of imidazo[2,1-b][1,3]oxazines and their promising potential against MDR-TB.

Type: Article
Title: Synthesis and Anti-Mycobacterium tuberculosis Activity of Imidazo[2,1-b][1,3]oxazine Derivatives against Multidrug-Resistant Strains
Location: Germany
Open access status: An open access version is available from UCL Discovery
DOI: 10.1002/cmdc.202300015
Publisher version: https://doi.org/10.1002/cmdc.202300015
Language: English
Additional information: © 2023 The Authors. ChemMedChem published by Wiley-VCH GmbH This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Keywords: 2-nitroimidazooxazine, Imidazo[2,1-b][1,3]oxazine, multidrug-resistant tuberculosis, pretomanid derivatives, tuberculosis
UCL classification: UCL
UCL > Provost and Vice Provost Offices > UCL BEAMS
UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Maths and Physical Sciences
UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Maths and Physical Sciences > Dept of Chemistry
URI: https://discovery-pp.ucl.ac.uk/id/eprint/10169323
Downloads since deposit
352Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item